Dual inhibition of BRAF and mTOR in BRAF(V600E)-mutant pediatric, adolescent, and young adult brain tumors

Although BRAF inhibition has demonstrated activity in BRAF(V600)–mutated brain tumors, ultimately these cancers grow resistant to BRAF inhibitor monotherapy. Parallel activation of the phosphatidylinositol 3-kinase-mammalian target of rapamycin pathway has been implicated as a mechanism of primary a...

Descripción completa

Detalles Bibliográficos
Autores principales: Sen, Shiraj, Tanaka, Ryuma, Khatua, Soumen, Zaky, Wafik, Janku, Filip, Penas-Prado, Marta, Weathers, Shiao-Pei, Behrang, Amini, Roszik, Jason, Subbiah, Vivek
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory Press 2020
Materias:
Research Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7476413/
https://www.ncbi.nlm.nih.gov/pubmed/32843426
http://dx.doi.org/10.1101/mcs.a005041

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7476413/
https://www.ncbi.nlm.nih.gov/pubmed/32843426
http://dx.doi.org/10.1101/mcs.a005041

Ejemplares similares